MENU
+Compare
ZVRA
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$7.68
Change
-$0.15 (-1.92%)
Capitalization
409.93M

ZVRA Zevra Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ZVRA with price predictions
Feb 18, 2025

ZVRA sees its Stochastic Oscillator ascends from oversold territory

On February 13, 2025, the Stochastic Oscillator for ZVRA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 71 instances where the indicator left the oversold zone. In of the 71 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 14, 2025. You may want to consider a long position or call options on ZVRA as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ZVRA just turned positive on February 13, 2025. Looking at past instances where ZVRA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZVRA advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

ZVRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZVRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ZVRA entered a downward trend on February 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.875) is normal, around the industry mean (12.604). P/E Ratio (0.000) is within average values for comparable stocks, (85.387). ZVRA's Projected Growth (PEG Ratio) (10.667) is very high in comparison to the industry average of (1.581). ZVRA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (13.351) is also within normal values, averaging (252.111).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZVRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ZVRA is expected to report earnings to fall 41.84% to -40 cents per share on February 28

Zevra Therapeutics ZVRA Stock Earnings Reports
Q4'24
Est.
$-0.40
Q3'24
Missed
by $0.28
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.07
Q4'23
Missed
by $0.24
The last earnings report on November 12 showed earnings per share of -68 cents, missing the estimate of -40 cents. With 329.53K shares outstanding, the current market capitalization sits at 409.93M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1180 Celebration Boulevard
Phone
+1 321 939-3416
Employees
69
Web
https://www.zevra.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ZVRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with ATXS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
-1.49%
ATXS - ZVRA
34%
Loosely correlated
-0.99%
RIGL - ZVRA
34%
Loosely correlated
-3.85%
CRNX - ZVRA
34%
Loosely correlated
+0.91%
KYMR - ZVRA
34%
Loosely correlated
+0.68%
QURE - ZVRA
32%
Poorly correlated
-6.56%
More